Clinical Trial Update: Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating anti-hormone therapy combining anastrazole and fulvestrant before surgery in postmenopausal women with invasive breast cancer; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Fulvestrant (fulvestrant)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Invasive Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-05-18